Back your fave M&As in Merger Madness

For the irrepressible matchmakers among you, we offer the Wall Street Journal Health Blog's annual March Madness bracket, pharma-style. This time, the subject is--yes--M&A. The blogsters have paired the engaged couples--Pfizer/Wyeth, Roche/Genentech, Eli Lilly/ImClone, Merck/Schering-Plough--and put together the wallflowers, too. So Johnson & Johnson is bracketed with Amgen, Sanofi-Aventis with Bristol-Myers Squibb, et al. Check it out. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.